Tobin W. Juvenal

Tobin W. Juvenal

Chief Commercial OfficeratCastle Biosciences· In proxies 2021–2025

Pay in FY2025-3% from the year before · Castle Biosciences stock +46.0% the same year

Tobin W. Juvenal was paid $2.4M in FY2025 (Dec), down 3%. Castle Biosciences stock rose 46.0% that year.

Pay$100 in the stock at the end of FY20 → $58
Pay is from the Summary Compensation Table of each Castle Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Castle BiosciencesPublic company · 5 yr
    • Chief Commercial Officer2021 – Present · 5 yrStock in role -49%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?